Latanoprost Yonsung

Latanoprost, the active ingredient in Latanoprost Yonsung, is a prostaglandin analog presented as a topical ophthalmic solution for ocular use. It lowers intraocular pressure and is used to treat open-angle glaucoma and ocular hypertension in adult patients.

GNH USA supplies Latanoprost Yonsung as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑compliant shipments to global markets, ensuring product integrity throughout the supply chain.

Latanoprost is indicated for conditions involving elevated intraocular pressure, primarily within the glaucoma and ocular hypertension disease families.

- Open-angle glaucoma: reduces intraocular pressure to help prevent optic nerve damage. - Ocular hypertension: lowers intraocular pressure to reduce risk of progression to glaucoma. - Elevated intraocular pressure (any cause): helps achieve target pressure levels. - Glaucoma suspect: provides pressure reduction to delay disease onset.

Latanoprost may cause a range of ocular and systemic reactions, most of which are mild and transient.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Eye irritation or foreign‑body sensation. - Increased eyelash length and thickness. - Darkening of the iris color. - Blurred vision shortly after instillation. - Mild eye pain or discomfort.

Serious or Rare Side Effects: - Severe ocular inflammation (uveitis or iritis). - Allergic reactions such as swelling, itching, or rash. - Sudden loss of vision or visual field defects. - Corneal ulcer or keratitis.

Before initiating therapy, clinicians should evaluate patient history and monitor ocular health.

- Monitor intraocular pressure: assess response after 4–6 weeks. - Assess for ocular infections: avoid use if active infection is present. - Caution in patients with a history of uveitis or ocular inflammation. - Avoid contact lens wear for at least 15 minutes after each dose. - Evaluate pregnancy and breastfeeding status: discuss potential risks with the prescriber. - Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost can interact with other ophthalmic agents, affecting efficacy or safety.

Major Interactions (Avoid): - Concurrent use of other prostaglandin analog eye drops: may increase risk of ocular side effects. - Non‑steroidal anti‑inflammatory eye drops: can diminish the pressure‑lowering effect.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: additive intraocular pressure reduction may require monitoring. - Topical corticosteroids: may reduce prostaglandin activity and lessen efficacy. - Ocular anesthetic drops: may increase irritation or discomfort when combined.